These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24375831)
1. Mutation analysis of a cohort of US patients with hemophilia B. Li T; Miller CH; Driggers J; Payne AB; Ellingsen D; Hooper WC Am J Hematol; 2014 Apr; 89(4):375-9. PubMed ID: 24375831 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B. Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250 [TBL] [Abstract][Full Text] [Related]
3. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review. Rydz N; Leggo J; Tinlin S; James P; Lillicrap D Am J Hematol; 2013 Dec; 88(12):1030-4. PubMed ID: 23913812 [TBL] [Abstract][Full Text] [Related]
4. Molecular genotyping of the Italian cohort of patients with hemophilia B. Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G; Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378 [TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B. Saini S; Hamasaki-Katagiri N; Pandey GS; Yanover C; Guelcher C; Simhadri VL; Dandekar S; Guerrera MF; Kimchi-Sarfaty C; Sauna ZE Haemophilia; 2015 Mar; 21(2):210-218. PubMed ID: 25470321 [TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations. Mårtensson A; Letelier A; Halldén C; Ljung R Haemophilia; 2016 May; 22(3):440-5. PubMed ID: 26612714 [TBL] [Abstract][Full Text] [Related]
7. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W; Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590 [TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with inhibitor development in Chinese patients with haemophilia B. Zhou J; Ding Q; Chen Z; Yang H; Lin L; Wang H; Wang X; Wu R Haemophilia; 2015 Jul; 21(4):e286-93. PubMed ID: 25929987 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations. Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744 [TBL] [Abstract][Full Text] [Related]
10. A genetic analysis of 23 Chinese patients with hemophilia B. Wang QY; Hu B; Liu H; Tang L; Zeng W; Wu YY; Cheng ZP; Hu Y Sci Rep; 2016 Apr; 6():25024. PubMed ID: 27109384 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene. Wulff K; Bykowska K; Lopaciuk S; Herrmann FH Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280 [TBL] [Abstract][Full Text] [Related]
12. Usual and unusual mutations in a cohort of Belgian patients with hemophilia B. Lannoy N; Lambert C; Farrugia A; Van Damme A; Hermans C Thromb Res; 2017 Jan; 149():25-28. PubMed ID: 27865967 [No Abstract] [Full Text] [Related]
13. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene. Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401 [TBL] [Abstract][Full Text] [Related]
14. The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide. Morgan GE; Figueiredo MS; Winship PR; Baker R; Bolton-Maggs PH; Brownlee GG Br J Haematol; 1995 Mar; 89(3):672-4. PubMed ID: 7734378 [TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect. Jenkins PV; Egan H; Keenan C; O'Shea E; Smith OP; Nolan B; White B; O'Donnell J Haemophilia; 2008 Jul; 14(4):717-22. PubMed ID: 18479429 [TBL] [Abstract][Full Text] [Related]
16. The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees. Lu Y; Wu X; Dai J; Ding Q; Wu W; Wang X Haemophilia; 2019 Mar; 25(2):316-323. PubMed ID: 30648777 [TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing. Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088 [TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: pattern of mutation and potential founder effects. Thorland EC; Weinshenker BG; Liu JZ; Ketterling RP; Vielhaber EL; Kasper CK; Ambriz R; Paredes R; Sommer SS Thromb Haemost; 1995 Dec; 74(6):1416-22. PubMed ID: 8772212 [TBL] [Abstract][Full Text] [Related]
19. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B. Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769 [TBL] [Abstract][Full Text] [Related]
20. Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability. Jourdy Y; Chatron N; Carage ML; Fretigny M; Meunier S; Zawadzki C; Gay V; Negrier C; Sanlaville D; Vinciguerra C J Thromb Haemost; 2016 Oct; 14(10):1988-1993. PubMed ID: 27477789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]